BRAINSTORM CELL THERAPEUTICS INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesIndenture • August 28th, 2024 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 28th, 2024 Company Industry JurisdictionINDENTURE, dated as of [●], 202[●] , among BRAINSTORM CELL THERAPEUTICS INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):